Literature DB >> 30707190

Lewy Body Dementias.

Melissa J Armstrong.   

Abstract

PURPOSE OF REVIEW: This article describes current diagnostic criteria relating to the diagnosis of Lewy body dementia, highlights diagnostic controversies, and reviews treatment approaches. RECENT
FINDINGS: Clinical diagnostic criteria for both Parkinson disease and dementia with Lewy bodies have been recently updated. These criteria result in overlap between individuals diagnosed with Parkinson disease and those with dementia with Lewy bodies. Although clinical features and symptomatic treatment overlap, differences remain in epidemiology and expected progression. The high prevalence of cognitive impairment in Parkinson disease supports regular screening for cognitive changes and counseling patients and families regarding what to expect. Treatment for Lewy body dementia involves avoiding medications that may cause or exacerbate symptoms; prescribing pharmacologic agents to address bothersome cognitive, behavioral, movement, and other nonmotor symptoms; recommending physical exercise and therapy; and providing education, counseling, caregiver support, and palliative care.
SUMMARY: Lewy body dementia includes both dementia with Lewy bodies and Parkinson disease dementia, overlapping clinicopathologic entities with differences relating to diagnosis and expected progression. Treatment is symptomatic and thus largely overlapping for the two conditions.

Entities:  

Mesh:

Year:  2019        PMID: 30707190     DOI: 10.1212/CON.0000000000000685

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  7 in total

Review 1.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

2.  Caregiver Support in a Case of Posttraumatic Stress Disorder and Lewy Body Dementia.

Authors:  Aaron A Kuntz; Ellen Wanninger; Brian Lewis
Journal:  Fed Pract       Date:  2022-05-13

3.  State of Knowledge on Molecular Adaptations to Exercise in Humans: Historical Perspectives and Future Directions.

Authors:  Kaleen M Lavin; Paul M Coen; Liliana C Baptista; Margaret B Bell; Devin Drummer; Sara A Harper; Manoel E Lixandrão; Jeremy S McAdam; Samia M O'Bryan; Sofhia Ramos; Lisa M Roberts; Rick B Vega; Bret H Goodpaster; Marcas M Bamman; Thomas W Buford
Journal:  Compr Physiol       Date:  2022-03-09       Impact factor: 8.915

Review 4.  Lewy Body Dementias: Controversies and Drug Development.

Authors:  Shannon Y Chiu; Dawn Bowers; Melissa J Armstrong
Journal:  Neurotherapeutics       Date:  2021-12-02       Impact factor: 6.088

5.  A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies.

Authors:  Giovanni Bellomo; Federico Paolini Paoletti; Elena Chipi; Maya Petricciuolo; Simone Simoni; Nicola Tambasco; Lucilla Parnetti
Journal:  Diagnostics (Basel)       Date:  2020-11-26

Review 6.  Lewy Body Dementias: A Coin with Two Sides?

Authors:  Ángela Milán-Tomás; Marta Fernández-Matarrubia; María Cruz Rodríguez-Oroz
Journal:  Behav Sci (Basel)       Date:  2021-06-22

Review 7.  Beyond the average patient: how neuroimaging models can address heterogeneity in dementia.

Authors:  Serena Verdi; Andre F Marquand; Jonathan M Schott; James H Cole
Journal:  Brain       Date:  2021-11-29       Impact factor: 13.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.